Correlation Between Anterix and Calmare Therapeutics
Can any of the company-specific risk be diversified away by investing in both Anterix and Calmare Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anterix and Calmare Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anterix and Calmare Therapeutics, you can compare the effects of market volatilities on Anterix and Calmare Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anterix with a short position of Calmare Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anterix and Calmare Therapeutics.
Diversification Opportunities for Anterix and Calmare Therapeutics
-0.02 | Correlation Coefficient |
Good diversification
The 3 months correlation between Anterix and Calmare is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Anterix and Calmare Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Calmare Therapeutics and Anterix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anterix are associated (or correlated) with Calmare Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Calmare Therapeutics has no effect on the direction of Anterix i.e., Anterix and Calmare Therapeutics go up and down completely randomly.
Pair Corralation between Anterix and Calmare Therapeutics
If you would invest 3,378 in Anterix on September 21, 2024 and sell it today you would lose (331.00) from holding Anterix or give up 9.8% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 0.61% |
| Values | Daily Returns |
Anterix vs. Calmare Therapeutics
Performance |
| Timeline |
| Anterix |
| Calmare Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Anterix and Calmare Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Anterix and Calmare Therapeutics
The main advantage of trading using opposite Anterix and Calmare Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anterix position performs unexpectedly, Calmare Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Calmare Therapeutics will offset losses from the drop in Calmare Therapeutics' long position.| Anterix vs. Liberty Broadband Srs | Anterix vs. Liberty Broadband Srs | Anterix vs. KT Corporation | Anterix vs. Telkom Indonesia Tbk |
| Calmare Therapeutics vs. Asure Software | Calmare Therapeutics vs. ServiceNow | Calmare Therapeutics vs. Anterix | Calmare Therapeutics vs. Videolocity International |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |